Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
T-cell activation requires clustering of a threshold number of T-cell receptors (TCRs) at the site of antigen presentation, a number that is reduced by CD28 co-receptor recruitment of signalling proteins to TCRs. Here we demonstrate that a deficiency in beta1,6 N-acetylglucosaminyltransferase V (Mgat5), an enzyme in the N-glycosylation pathway, lowers T-cell activation thresholds by directly enhancing TCR clustering. Mgat5-deficient mice showed kidney autoimmune disease, enhanced delayed-type hypersensitivity, and increased susceptibility to experimental autoimmune encephalomyelitis. Recruitment of TCRs to agonist-coated beads, TCR signalling, actin microfilament re-organization, and agonist-induced proliferation were all enhanced in Mgat5-/- T cells. Mgat5 initiates GlcNAc beta1,6 branching on N-glycans, thereby increasing N-acetyllactosamine, the ligand for galectins, which are proteins known to modulate T-cell proliferation and apoptosis. Indeed, galectin-3 was associated with the TCR complex at the cell surface, an interaction dependent on Mgat5. Pre-treatment of wild-type T cells with lactose to compete for galectin binding produced a phenocopy of Mgat5-/- TCR clustering. These data indicate that a galectin-glycoprotein lattice strengthened by Mgat5-modified glycans restricts TCR recruitment to the site of antigen presentation. Dysregulation of Mgat5 in humans may increase susceptibility to autoimmune diseases, such as multiple sclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and glycan branching is speci fi cally upregulated in T-cell activation (598), and in malignant transformation (599 -604).”
From Biological roles of glycans (2017) · cites this paper as [598]
Citations
Cites
Three-dimensional segregation of supramolecular activation clusters in T cells
Monks, C. R. F., Freiberg, B. A., Kupfer, H., Sciaky, N., & Kupfer, A. (1998) · Nature · doi:10.1038/25764 · Cited by 1,968
Robustness in simple biochemical networks
Barkai, N., & Leibler, S. (1997) · Nature · doi:10.1038/43199 · Cited by 1,513 · cited 1×
“This form of slow-negative regulation governed by steady-state activity of the system is a key feature of robust and adaptive biochemical pathway”
BackgroundSerial triggering of many T-cell receptors by a few peptide–MHC complexes
Valitutti, S., Müller, S., Cella, M., Padovan, E., & Lanzavecchia, A. (1995) · Nature · doi:10.1038/375148a0 · Cited by 1,128
Apoptosis of T cells mediated by galectin-1
Perillo, N. L., Pace, K. E., Seilhamer, J. J., & Baum, L. G. (1995) · Nature · doi:10.1038/378736a0 · Cited by 1,074 · cited 1×
“, which are proteins known to modulate T-cell proliferation and apoptosi”
BackgroundT Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds
Viola, A., & Lanzavecchia, A. (1996) · Science · doi:10.1126/science.273.5271.104 · Cited by 1,023
T Lymphocyte Costimulation Mediated by Reorganization of Membrane Microdomains
Viola, A., Schroeder, S., Sakakibara, Y., & Lanzavecchia, A. (1999) · Science · doi:10.1126/science.283.5402.680 · Cited by 938
Stimulation of p21ras upon T-cell activation
Downward, J., Graves, J. D., Warne, P. H., Rayter, S., & Cantrell, D. A. (1990) · Nature · doi:10.1038/346719a0 · Cited by 860 · cited 1×
“In T cells, L-PHA induces signalling common to TCR engagement, including phosphorylation of CD3ζ, Ca 2p mobilization, PKC-γ and Ras/mitogen-activated protein kinase (Mapk) activatio”
BackgroundFringe is a glycosyltransferase that modifies Notch
Moloney, D. J., Panin, V. M., Johnston, S. H., Chen, J., Shao, L., Wilson, R., Wang, Y., Stanley, P., Irvine, K. D., Haltiwanger, R. S., et al. (2000) · Nature · doi:10.1038/35019000 · Cited by 852
A Receptor/Cytoskeletal Movement Triggered by Costimulation During T Cell Activation
Wülfing, C., & Davis, M. M. (1998) · Science · doi:10.1126/science.282.5397.2266 · Cited by 610
Suppression of tumor growth and metastasis in Mgat5-deficient mice
Granovsky, M., Fata, J., Pawling, J., Muller, W. J., Khokha, R., & Dennis, J. W. (2000) · Nature Medicine · doi:10.1038/73163 · Cited by 569
Self-citation
Cited by
Items 101–200 of 904
Mechanisms of disease: The human N-glycome
Lauc, G., Pezer, M., Rudan, I., & Campbell, H. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.10.016 · Cited by 184
“For example, mouse strains with deficiencies in glycan branching, are hypersensitive to autoimmune disease [72], while modification of sialic acids on membrane glycoproteins by sialic acid acetylesterase is important in peripheral B cell tolerance [73] and functionally deficient germline variants of this gene represen…”
BackgroundThe dark and bright side of atherosclerotic calcification
Pugliese, G., Iacobini, C., Fantauzzi, C. B., & Menini, S. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.011 · Cited by 184
“This process may be also favored by the anti-inflammatory effects of this lectin, including the negative regulation of T-cell activation [80] and the induction of alternative macrophage activation [81].”
BackgroundZuberi, R. I., Hsu, D. K., Kalayci, O., Chen, H.-Y., Sheldon, H. K., Yu, L., Apgar, J. R., Kawakami, T., Lilly, C. M., & Liu, F.-T. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63255-5 · Cited by 184
CD8 Binding to MHC Class I Molecules Is Influenced by T Cell Maturation and Glycosylation
Daniels, M. A., Devine, L., Miller, J. D., Moser, J. M., Lukacher, A. E., Altman, J. D., Kavathas, P., Hogquist, K. A., & Jameson, S. C. (2001) · Immunity · doi:10.1016/s1074-7613(01)00252-7 · Cited by 184
The MUC1 and Galectin-3 Oncoproteins Function in a MicroRNA-Dependent Regulatory Loop
Ramasamy, S., Duraisamy, S., Barbashov, S., Kawano, T., Kharbanda, S., & Kufe, D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.031 · Cited by 180
“At the cell surface, galectin-3 binds to N-glycans on EGF, TGFb, and T cell receptors (Demetriou et al., 2001; Partridge et al., 2004).”
BackgroundDemotte, N., Stroobant, V., Courtoy, P. J., Van Der Smissen, P., Colau, D., Luescher, I. F., Hivroz, C., Nicaise, J., Squifflet, J.-L., Mourad, M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.01.011 · Cited by 185
Physiological Regulation of the Immunological Synapse by Agrin
Khan, A. A., Bose, C., Yam, L. S., Soloski, M. J., & Rupp, F. (2001) · Science · doi:10.1126/science.1056594 · Cited by 179
Galectin-3 Exerts Cytokine-Like Regulatory Actions through the JAK–STAT Pathway
Jeon, S.-B., Yoon, H. J., Chang, C. Y., Koh, H. S., Jeon, S.-H., & Park, E. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000154 · Cited by 178
“In addition, it has been reported that galectin-3 functions by interacting with cell surface receptors including CD98, CD11b/18, and TCR complex at the cell surface (33, 55).”
BackgroundIhara, S., Miyoshi, E., Ko, J. H., Murata, K., Nakahara, S., Honke, K., Dickson, R. B., Lin, C.-Y., & Taniguchi, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200673200 · Cited by 175
Demotte, N., Wieërs, G., Van Der Smissen, P., Moser, M., Schmidt, C., Thielemans, K., Squifflet, J.-L., Weynand, B., Carrasco, J., Lurquin, C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0761 · Cited by 179
“The authors were the first to propose that reduced N-glycosylation, resulting in looser glycoprotein/galectin lattices, could improve TCR clustering at the immune synapse (46).”
BackgroundKajihara, Y., Suzuki, Y., Yamamoto, N., Sasaki, K., Sakakibara, T., & Juneja, L. R. (2004) · Chemistry – A European Journal · doi:10.1002/chem.200305115 · Cited by 176
Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis
Mkhikian, H., Grigorian, A., Li, C. F., Chen, H.-L., Newton, B., Zhou, R. W., Beeton, C., Torossian, S., Tatarian, G. G., Lee, S.-U., et al. (2011) · Nature Communications · doi:10.1038/ncomms1333 · Cited by 174
Self-citationRegulation of ZAP-70 Activation and TCR Signaling by Two Related Proteins, Sts-1 and Sts-2
Carpino, N., Turner, S., Mekala, D., Takahashi, Y., Zang, H., Geiger, T. L., Doherty, P., & Ihle, J. N. (2004) · Immunity · doi:10.1016/s1074-7613(03)00351-0 · Cited by 168
Galectin‐3 regulates T‐cell functions
Hsu, D. K., Chen, H., & Liu, F. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00798.x · Cited by 166
“The most prominent example, and one that is highly relevant to this review is the characterization of TCR signaling in Mgat5 ⁄ ) mice (4).”
BackgroundInfluentialZhuo, Y., Chammas, R., & Bellis, S. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m8000015200 · Cited by 164
Glycans as Key Checkpoints of T Cell Activity and Function
Pereira, M. S., Alves, I., Vicente, M., Campar, A., Silva, M. C., Padrão, N. A., Pinto, V., Fernandes, Â., Dias, A. M., & Pinho, S. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02754 · Cited by 163
Cloos, P. A., & Christgau, S. (2004) · Biogerontology · doi:10.1023/b:bgen.0000031152.31352.8b · Cited by 169
“Thus, it was recently reported that deletion of the b1 6N-acetyl glucosaminyl transferase V (Mgat5) gene in mice, which encodes an enzyme involved in the N-glycosylation pathway caused systemic autoimmunity in mice (Demetriou et al. 2001).”
BackgroundHokama, A., Mizoguchi, E., Sugimoto, K., Shimomura, Y., Tanaka, Y., Yoshida, M., Rietdijk, S. T., de Jong, Y. P., Snapper, S. B., Terhorst, C., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.05.009 · Cited by 171
Gao, X., Zhi, Y., Sun, L., Peng, X., Zhang, T., Xue, H., Tai, G., & Zhou, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.482315 · Cited by 154
Morgan, R., Gao, G., Pawling, J., Dennis, J. W., Demetriou, M., & Li, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7200 · Cited by 153
“Mgat5-modified N -glycans on TCR regulate TCR association with a multivalent galectin-glycoprotein lattice that restricts ligand-induced TCR recruitment to the immune synapse (7).”
BackgroundInfluentialSelf-citationGalectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis
Méndez-Huergo, S. P., Blidner, A. G., & Rabinovich, G. A. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.12.003 · Cited by 152
“Moreover, galectin-3 prevents TCR, CD4 and Lck clustering into GM1enriched membrane microdomains, thereby adjusting T-cell signaling threshold through N-glycan-dependent mechanisms [39,40].”
BackgroundYamamoto, S., Oka, S., Inoue, M., Shimuta, M., Manabe, T., Takahashi, H., Miyamoto, M., Asano, M., Sakagami, J., Sudo, K., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200296200 · Cited by 154
Germ Cell Survival Through Carbohydrate-Mediated Interaction with Sertoli Cells
Akama, T. O., Nakagawa, H., Sugihara, K., Narisawa, S., Ohyama, C., Nishimura, S.-I., O'Brien, D. A., Moremen, K. W., Millán, J. L., & Fukuda, M. N. (2002) · Science · doi:10.1126/science.1065570 · Cited by 154
Kuball, J., Hauptrock, B., Malina, V., Antunes, E., Voss, R.-H., Wolfl, M., Strong, R., Theobald, M., & Greenberg, P. D. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082487 · Cited by 151
Identification of Self Through Two-Dimensional Chemistry and Synapses
Dustin, M. L., Bromley, S. K., Davis, M. M., & Zhu, C. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.133 · Cited by 163
“A deficiency in the enzymes that regulate production of galectin-1 binding sites on T cells suggests that the interaction of the bivalent lectin galectin-1 has an inhibitory effect on T cell activation through a retarding effect on immunological synapse formation (Demetriou et al. 2001).”
BackgroundVasconcelos-dos-Santos, A., Oliveira, I. D. A., Lucena, M. C., Mantuano, N. R., Whelan, S. A., Dias, W. B., & Todeschini, A. R. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00138 · Cited by 176
“The latter effect is most probably due to the β1-6G1cNAcbranching increasing galectin binding and retention of growth receptors on the cell surface (75, 124, 125).”
BackgroundAutoantigenesis: the evolution of protein modifications in autoimmune disease
Doyle, H. A., & Mamula, M. J. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.12.003 · Cited by 151
T-cell signalling and autoimmunity: molecular mechanisms of disease
Ohashi, P. S. (2002) · Nature reviews. Immunology · doi:10.1038/nri822 · Cited by 181
“Recent studies have shown that glycosylation events, cell-cycle progression and the function of antigen-presenting cells are linked to autoimmune disease as wel”
BackgroundSeeing strangers or announcing “danger”: Galectin-3 in two models of innate immunity
Sato, S., & Nieminen, J. (2002) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000014089.17121.cc · Cited by 160
Control of T Cell-mediated Autoimmunity by Metabolite Flux to N-Glycan Biosynthesis
Grigorian, A., Lee, S.-U., Tian, W., Chen, I.-J., Gao, G., Mendelsohn, R., Dennis, J. W., & Demetriou, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701890200 · Cited by 146
Self-citationGalectin-3 and cancer stemness
Nangia‐Makker, P., Hogan, V. A., & Raz, A. (2018) · Glycobiology · doi:10.1093/glycob/cwy001 · Cited by 152
Verhelst, X., Dias, A. M., Colombel, J., Vermeire, S., Vlierberghe, H. V., Callewaert, N., & Pinho, S. S. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.08.060 · Cited by 159
Congenital disorders of glycosylation (CDG): It's all in it!
Jaeken, J. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1024431131208 · Cited by 177
“Yeast mutants and particularly mouse models will become increasing valuable in these areas (Aebi and Hennet, 2001; Asano et al 1997; Bhattacharyya et al 2002; Chui et al 2001; Demetriou et al 2001, Freeze 2002; Smith et al 2002; Stanley and Ioffe 1995; Wang et al 2001; Zak et al 2002).”
BackgroundBernardes, E. S., Silva, N. M., Ruas, L. P., Mineo, J. R., Loyola, A. M., Hsu, D. K., Liu, F., Chammas, R. J., & Roque‐Barreira, M. C. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050636 · Cited by 137
“However, the strongest data suggesting a role for galectin-3 in adaptive immunity came from studies with mice deficient in UDP-N-acetylglucosaminyltransferase V (Mgat5).(53) These mice showed increased TCR activation, susceptibility to autoimmune disease, and enhanced Th1 response, all attributed to the inefficient fo…”
BackgroundChen, I.-J., Chen, H.-L., & Demetriou, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706923200 · Cited by 136
Self-citationCastilho, A., Gattinger, P., Grass, J., Jez, J., Pabst, M., Altmann, F., Gorfer, M., Strasser, R., & Steinkellner, H. (2011) · Glycobiology · doi:10.1093/glycob/cwr009 · Cited by 136
“The branched structures are associated with various biological functions including cancer metastasis (reviewed by Zhao et al. 2008) and regulation of T-cell activation (Demetriou et al. 2001).”
Roles of mucin-type O-glycans in cell adhesion
Fukuda, M. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00409-9 · Cited by 136
Rabinovich, G. A., & Gruppi, A. (2005) · Parasite Immunology · doi:10.1111/j.1365-3024.2005.00749.x · Cited by 142
T‐cell growth, cell surface organization, and the galectin–glycoprotein lattice
Grigorian, A., Torossian, S., & Demetriou, M. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00796.x · Cited by 133
“Indeed, experiments removing defined N-glycosylation sites in the TCR constant domain as well as deficiency in Mgat5 both reduce avidity of TCR for galectins and enhance the effective avidity for peptide– MHC (35) and anti-CD3 antibody (1), respectively.”
BackgroundMethodInfluentialSelf-citationWang, Y., Tan, J., Sutton-Smith, M., Ditto, D., Panico, M., Campbell, R. M., Varki, N. M., Long, J. M., Jaeken, J., Levinson, S. R., et al. (2001) · Glycobiology · doi:10.1093/glycob/11.12.1051 · Cited by 134
“Genetic defects in N-glycan branching have been found to alter immune function with pathologic consequences (Chui et al., 2001; Demetriou et al., 2001).”
BackgroundInfluentialGalectins in acute and chronic inflammation
Liu, F., Yang, R., & Hsu, D. K. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06386.x · Cited by 130
Regulation of Tumor Progression by Extracellular Galectin-3
Nangia‐Makker, P., Balan, V., & Raz, A. (2008) · Cancer Microenvironment · doi:10.1007/s12307-008-0003-6 · Cited by 134
Galectins in the tumor endothelium: opportunities for combined cancer therapy
Thijssen, V. L. J. L., Poirier, F., Baum, L. G., & Griffioen, A. W. (2007) · Blood · doi:10.1182/blood-2007-03-077792 · Cited by 132
John, C. M., Leffler, H., Kahl‐Knutsson, B., Svensson, I., & Jarvis, G. A. (2003) · PubMed · Cited by 130
Monomeric TCRs drive T cell antigen recognition
Brameshuber, M. O., Kellner, F., Rossboth, B. K., Ta, H., Alge, K., Sevcsik, E., Göhring, J., Axmann, M., Baumgart, F., Gascoigne, N. R. J., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0092-4 · Cited by 130
Srikrishna, G., Huttunen, H. J., Johansson, L., Weigle, B., Yamaguchi, Y., Rauvala, H., & Freeze, H. H. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00796.x · Cited by 129
“Deficiency of b1,6 GlcNAc transferase (Mgat-5) lowers T-cell activation threshold by enhancing T-cell receptor clustering (Demetriou et al. 2001), and multivalent galectin-Mgat-5 modified glycoprotein lattices limit agonist-mediated clustering.”
BackgroundStructural mechanisms of costimulation
Schwartz, J.-C. D., Zhang, X., Nathenson, S. G., & Almo, S. C. (2002) · Nature Immunology · doi:10.1038/ni0502-427 · Cited by 146
“This interferes with the recruitment of TCRs to the immunological synapse, resulting in down-regulation of T cell activit”
Evolving Mechanistic Insights into Galectin Functions
Arthur, C. M., Dias‐Baruffi, M., Cummings, R. D., & Stowell, S. R. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1396-1_1 · Cited by 145
“Consistent with this, Mgat5 KO recipients display heightened T cell activation and an increased propensity to develop autoimmunity [48].”
BackgroundInfluentialGalectin-3: an emerging all-out player in metabolic disorders and their complications
Pugliese, G., Iacobini, C., Pesce, C. M., & Menini, S. (2014) · Glycobiology · doi:10.1093/glycob/cwu111 · Cited by 137
“In particular, Chen et al. (2009) attributed this effect to TCR downregulation promoted by intracellular galectin-3, whereas Demetriou et al. (2001) showed that the galectin-glycoprotein lattice on the cell surface restricts TCR recruitment and clustering, which are required for T-cell activation…”
BackgroundNachtigal, M., Ghaffar, A., & Mayer, E. P. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070348 · Cited by 129
The roles of Galectin-3 in autoimmunity and tumor progression
Radosavljevic, G. D., Volarević, V., Jovanović, I., Milovanović, M., Pejnovic, N. N., Arsenijević, N., Hsu, D. K., & Lukić, M. L. (2012) · Immunologic Research · doi:10.1007/s12026-012-8286-6 · Cited by 146
“Earlier report [25] has shown that reduction in Galectin-3 functions through the deletion of Mgat5 (b1, 6N-acetylglucosaminyltransferase V) in mice and leads to heightened susceptibility to EAE.”
BackgroundInfluentialGalectin-3 interacts with naïve and primed neutrophils, inducing innate immune responses
Nieminen, J., St-Pierre, C., & Sato, S. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1204702 · Cited by 126
“It has also been indicated that the galectin-3 lattice reduces the lateral movement of T cell receptor (TCR), restricting TCR recruitment to the site of antigen presentation [71].”
BackgroundGrigorian, A., Araujo, L., Naidu, N. N., Place, D. J., Choudhury, B., & Demetriou, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277814 · Cited by 140
Self-citationThe regulatory power of glycans and their binding partners in immunity
Johnson, J. L., Jones, M. B., Ryan, S. O., & Cobb, B. A. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.01.006 · Cited by 125
Altered N‐glycosylation profiles as potential biomarkers and drug targets in diabetes
Rudman, N., Gornik, O., & Lauc, G. (2019) · FEBS Letters · doi:10.1002/1873-3468.13495 · Cited by 140
Sioud, M., Mobergslien, A., Boudabous, A., & Fløisand, Y. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02378.x · Cited by 123
Glycosylation in the Tumor Microenvironment: Implications for Tumor Angiogenesis and Metastasis
Chandler, K. B., Costello, C. E., & Rahimi, N. (2019) · Cells · doi:10.3390/cells8060544 · Cited by 136
Fowler, M. I., Thomas, R. J., Atherton, J. C., Roberts, I. S., & High, N. J. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00599.x · Cited by 125
Activation of Murine CD4+ and CD8+ T Lymphocytes Leads to Dramatic Remodeling of N-Linked Glycans
Comelli, E. M., Sutton-Smith, M., Yan, Q., Amado, M., Panico, M., Gilmartin, T., Whisenant, T., Lanigan, C. M., Head, S. R., Goldberg, D., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2431 · Cited by 126
Polylactosamine on glycoproteins influences basal levels of lymphocyte and macrophage activation
Togayachi, A., Kozono, Y., Ishida, H., Abe, S., Suzuki, N., Tsunoda, Y., Hagiwara, K., Kuno, A., Ohkura, T., Sato, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707426104 · Cited by 124
Metabolic Reprogramming by Hexosamine Biosynthetic and Golgi N-Glycan Branching Pathways
Ryczko, M. C., Pawling, J., Chen, R., Abdel Rahman, A. M., Yau, K., Copeland, J. K., Zhang, C., Surendra, A., Guttman, D. S., Figeys, D., et al. (2016) · Scientific Reports · doi:10.1038/srep23043 · Cited by 117
Self-citationTranslating the ‘Sugar Code’ into Immune and Vascular Signaling Programs
Cerliani, J. P., Blidner, A. G., Toscano, M. A., Croci, D. O., & Rabinovich, G. A. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.11.003 · Cited by 126
1H-1,2,3-Triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors
Salameh, B. A. B., Cumpstey, I., Sundin, A., Leffler, H., & Nilsson, U. J. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.05.040 · Cited by 126
Liquid-liquid phase separation and extracellular multivalent interactions in the tale of galectin-3
Chiu, Y.-P., Sun, Y.-C., Qiu, D.-C., Lin, Y.-H., Chen, Y.-Q., Kuo, J.-C., & Huang, J.-R. (2020) · Nature Communications · doi:10.1038/s41467-020-15007-3 · Cited by 115
Pelletier, I., & Sato, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201562200 · Cited by 114
Sasai, K., Ikeda, Y., Fujii, T., Tsuda, T., & Taniguchi, N. (2002) · Glycobiology · doi:10.1093/glycob/12.2.119 · Cited by 117
Multivalent Lectin—Carbohydrate Interactions
Dam, T. K., & Brewer, C. F. (2010) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/s0065-2318(10)63005-3 · Cited by 127
Progress in Molecular and Genetic Studies of IgA Nephropathy
Novák, J., Julian, B. A., Tomana, M., & Mestecky, J. (2001) · Journal of Clinical Immunology · doi:10.1023/a:1012284402054 · Cited by 113
Liu, W., Hsu, D. K., Chen, H.-Y., Yang, R.-Y., Carraway, K. L., Isseroff, R. R., & Liu, F.-T. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.211 · Cited by 116
“Galectin-3 can interact extracellularly with cell surface glycoproteins and influence a variety of cellular responses as well as modulate the properties of cell surface receptors (Demetriou et al ., 2001; Partridge et al ., 2004).”
Metabolic control of T cell immune response through glycans in inflammatory bowel disease
Dias, A. M., Correia, A., Pereira, M. S., Almeida, C. R., Alves, I., Pinto, V., Catarino, T. A., Mendes, N. M., Leander, M., Oliva-Teles, M. T., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720409115 · Cited by 134
“In fact, mice deficient in the MGAT5 gene display an increased susceptibility to autoimmune diseases (7, 10, 11).”
BackgroundResultInfluentialStructure and mechanism of cancer-associated N-acetylglucosaminyltransferase-V
Nagae, M., Kizuka, Y., Mihara, E., Kitago, Y., Hanashima, S., Ito, Y., Takagi, J., Taniguchi, N., & Yamaguchi, Y. (2018) · Nature Communications · doi:10.1038/s41467-018-05931-w · Cited by 113
Decoding sugar functions by identifying target glycoproteins
Taniguchi, N., Miyoshi, E., Jianguo, G., Honke, K., & Matsumoto, A. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.08.011 · Cited by 115
Dam, T. K., Gerken, T. A., & Brewer, C. F. (2009) · Biochemistry · doi:10.1021/bi9002919 · Cited by 128
“This, in turn, results in signal transduction effects that include apoptosis of T cells (8,9), regulation of the T-cell receptor (10,11), regulation of the location and activity of the Glut-2 transporter in pancreatic beta cells (12), and regulation cell cycling kinetics and activities of cytokine receptors (13).”
BackgroundTumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
Mantuano, N. R., Natoli, M., Zippelius, A., & Laubli, H. P. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001222 · Cited by 127
Breuilh, L., Vanhoutte, F., Fontaine, J., van Stijn, C. M. W., Tillie-Leblond, I., Capron, M., Faveeuw, C., Jouault, T., van Die, I., Gosset, P., et al. (2007) · Infection and Immunity · doi:10.1128/iai.02006-06 · Cited by 109
“For instance, extracellular Gal-3, by associating with N-glycans on T-cell receptor (TCR) has been shown to down-modulate TCR responsiveness and to regulate the production of Th1 and Th2 cytokines by differentiated T cells (13, 35).”
BackgroundInfluentialSun, Z.-Y. J., Kim, S. T., Kim, I. C., Fahmy, A., Reinherz, E. L., & Wagner, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407576101 · Cited by 121
N-Glycan Processing Deficiency Promotes Spontaneous Inflammatory Demyelination and Neurodegeneration
Lee, S.-U., Grigorian, A., Pawling, J., Chen, I.-J., Gao, G., Mozaffar, T., McKerlie, C., & Demetriou, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704839200 · Cited by 108
Self-citationQuaternary solution structures of galectins-1, -3, and -7
Morris, S., Ahmad, N., André, S., Kaltner, H., Gabius, H.-J., Brenowitz, M., & Brewer, F. (2003) · Glycobiology · doi:10.1093/glycob/cwh029 · Cited by 127
Ligand Reduces Galectin-1 Sensitivity to Oxidative Inactivation by Enhancing Dimer Formation
Stowell, S. R., Cho, M., Feasley, C. L., Arthur, C. M., Song, X., Colucci, J. K., Karmakar, S., Mehta, P., Dias‐Baruffi, M., McEver, R. P., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808925200 · Cited by 106
Hydrogenases: Hydrogen-Activating Enzymes
Frey, M. (2002) · ChemBioChem · doi:10.1002/1439-7633(20020301)3:2/3<153::aid-cbic153>3.0.co;2-b · Cited by 816
Signatures of human regulatory T cells: an encounter with old friends and new players
Pfoertner, S., Jeron, A., Probst-Kepper, M., Guzman, C. A., Hansen, W., Westendorf, A. M., Toepfer, T., Schrader, A. J., Franzke, A., Buer, J., et al. (2006) · Genome Biology · doi:10.1186/gb-2006-7-7-r54 · Cited by 107
“Whereas its secretion triggers apoptotic signal cascades in T cells [42], intracellular expressed LGALS3 acts as an antiapoptotic molecule [43-45].”
BackgroundSchnaar, R. L. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.057 · Cited by 109
Galectin-3 Regulates Integrin α2β1-mediated Adhesion to Collagen-I and -IV
Friedrichs, J., Manninen, A., Müller, D. J., & Helenius, J. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803634200 · Cited by 109
Specific Recognition of Leishmania major Poly-β-galactosyl Epitopes by Galectin-9
Pelletier, I., Hashidate, T., Urashima, T., Nishi, N., Nakamura, T., Futai, M., Arata, Y., Kasai, K.-I., Hirashima, M., Hirabayashi, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302693200 · Cited by 104
Galectin-9 binds IgM-BCR to regulate B cell signaling
Cao, A., Alluqmani, N., Buhari, F. H. M., Wasim, L., Smith, L. K., Quaile, A. T., Shannon, M., Hakim, Z., Furmli, H., Owen, D. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05771-8 · Cited by 105
Biological Modulation by Lectins and Their Ligands in Tumor Progression and Metastasis
Raz, A., & Nakahara, S. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008783330833 · Cited by 107
Voss, M., Künzel, U., Higel, F., Kuhn, P., Colombo, A., Fukumori, A., Haug‐Kröper, M., Klier, B., Grammer, G., Seidl, A., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201488375 · Cited by 106
“On the other hand, loss of b 1,6GlcNAc branching results in hyper-reactive T cells and autoimmune disorders in mice (Demetriou et al , 2001).”
Miceli, M. C., Moran, M., Chung, C. D., Patel, V. P., Low, T. A., & Zinnanti, W. J. (2001) · Seminars in Immunology · doi:10.1006/smim.2000.0303 · Cited by 110
Glycobiology of rheumatic diseases
Kissel, T., Toes, R. E. M., Huizinga, T. W. J., & Wuhrer, M. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00867-4 · Cited by 119
Dynamic Plasma Membrane Organization: A Complex Symphony
van Deventer, S. J., Arp, A. B., & van Spriel, A. B. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.11.004 · Cited by 112
Clark, M. C., Pang, M., Hsu, D. K., Liu, F., de Vos, S., Gascoyne, R. D., SAID, J. W., & Baum, L. G. (2012) · Blood · doi:10.1182/blood-2012-06-438234 · Cited by 101
Boscher, C., Zheng, Y. Z., Lakshminarayan, R., Johannes, L., Dennis, J. W., Foster, L. J., & Nabi, I. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.353334 · Cited by 113
Self-citationThe direct and indirect effects of glycans on immune function
Baum, L. G., & Cobb, B. A. (2017) · Glycobiology · doi:10.1093/glycob/cwx036 · Cited by 108
The Macrophage αMβ2 Integrin αM Lectin Domain Mediates the Phagocytosis of Chilled Platelets
Josefsson, E. C., Gebhard, H. H., Stossel, T. P., Hartwig, J. H., & Hoffmeister, K. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501178200 · Cited by 98
Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy
Rath, J. A., & Arber, C. (2020) · Cells · doi:10.3390/cells9061485 · Cited by 115
Tran, K. A., Pernet, E., Sadeghi, M., Downey, J., Chronopoulos, J., Lapshina, E., Tsai, O., Kaufmann, E., Ding, J., & Divangahi, M. (2024) · Nature Immunology · doi:10.1038/s41590-023-01739-z · Cited by 121
“Transcrip-tomic analysis revealed upregulation of several genes associated with T cell activation and memory formation ( Mgat5 , Cldnd2 , Itgax , Spn , Ly9 , Tnfrsf25 , Kcnj8 , S100a4 , Art2b ), which supports their identity as effector memory T cells 64,65 .”
Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments
Cardoso, A. C. F., Andrade, L. N. D. S., Bustos, S. O., & Chammas, R. J. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00127 · Cited by 107
“As mentioned earlier, extracellular galectin-3 is described to act at membrane proteins clusters through lattice formation (33, 134), promoting homotypic and heterotypic interactions and regulating substratum adhesion and receptor dynamics at the plasma membrane (135, 136).”
Backgroundde Kivit, S., Kraneveld, A. D., Garssen, J., & Willemsen, L. E. M. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.086 · Cited by 94
Dennis, J. W., Pawling, J., Cheung, P., Partridge, E. A., & Demetriou, M. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00411-7 · Cited by 108
Self-citationRabinovich, G. A., & Ilarregui, J. M. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00787.x · Cited by 92
“modulate TCR responses (103, 104), galectin-1 might also”
Background
Metadata
- Authors
- Demetriou, M., Granovsky, M., Quaggin, S., & Dennis, J. W.
- Affiliations
- Mount Sinai Hospital (CA)
- Corresponding author
- Dennis, James W.
- Venue
- Nature
- Published
- 2001-02
- Volume
- 409
- Issue
- 6821
- Pages
- 733-739
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1541131175
- Cited by
- 901
- References
- 31
- Citations by year
- 2026: 21 · 2025: 41 · 2024: 33 · 2023: 28 · 2022: 29 · 2021: 23 · 2020: 44 · 2019: 33 · 2018: 47 · 2017: 25 · 2016: 32 · 2015: 33 · 2014: 33 · 2013: 27 · 2012: 52
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Galectins and Cancer Biology
- Keywords
- MGAT5, N-glycosylation, T cell activation, galectin-3, autoimmunity, experimental autoimmune encephalomyelitis, delayed-type hypersensitivity, N-acetyllactosamine, multiple sclerosis, kidney autoimmunity
- MeSH terms
- Animals, Antigens, Differentiation, Glycosylation, Humans, Hypersensitivity, Delayed, Lymphocyte Activation, Major Histocompatibility Complex, Polysaccharides, Receptors, Antigen, T-Cell, T-Lymphocytes, Signal Transduction, Autoimmunity, N-Acetylglucosaminyltransferases, Galectin 3, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.